BAX and neoplasm: In a very recent paper, Peng et al. [55] showed that mutation of the two ubiquitin-binding sites in the pro-apoptotic protein BAX increased its half-life and its ability to activate the intrinsic pathway of apoptosis in HCT116 tumor cells.